347 related articles for article (PubMed ID: 23906320)
21. Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.
Gomes JA; Campi-Azevedo AC; Teixeira-Carvalho A; Silveira-Lemos D; Vitelli-Avelar D; Sathler-Avelar R; Peruhype-Magalhães V; Silvestre KF; Batista MA; Schachnik NC; Correa-Oliveira R; Eloi-Santos S; Martins-Filho OA
Immunobiology; 2012 Oct; 217(10):1005-16. PubMed ID: 22387073
[TBL] [Abstract][Full Text] [Related]
22. Specific activation of CD4
Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
[TBL] [Abstract][Full Text] [Related]
23. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
24. Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies.
Gea S; Ordonez P; Cerban F; Iosa D; Chizzolini C; Vottero-Cima E
Am J Trop Med Hyg; 1993 Nov; 49(5):581-8. PubMed ID: 7504407
[TBL] [Abstract][Full Text] [Related]
25. [Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].
Llano M; Pavía P; Flórez AC; Cuéllar A; González JM; Puerta C
Biomedica; 2014; 34(2):228-36. PubMed ID: 24967928
[TBL] [Abstract][Full Text] [Related]
26. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.
Cunha-Neto E; Coelho V; Guilherme L; Fiorelli A; Stolf N; Kalil J
J Clin Invest; 1996 Oct; 98(8):1709-12. PubMed ID: 8878420
[TBL] [Abstract][Full Text] [Related]
27. Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease.
Vasconcelos RH; Amaral FN; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
Hum Immunol; 2010 Oct; 71(10):964-7. PubMed ID: 20659514
[TBL] [Abstract][Full Text] [Related]
28. Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli.
O'Daly JA; Carrasco H; Fernandez V; Rodríguez MB
Acta Trop; 1994 Apr; 56(4):265-87. PubMed ID: 8023751
[TBL] [Abstract][Full Text] [Related]
29. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
Zúñiga E; Montes C; Barbieri G; Gruppi A
Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients.
Vasconcelos RH; Azevedo EA; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
Hum Immunol; 2011 May; 72(5):402-5. PubMed ID: 21371515
[TBL] [Abstract][Full Text] [Related]
31. β1-selective adrenoceptor antagonists increase plasma levels of anti-p2β antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease.
Vicco MH; Pujato N; Bontempi I; Rodeles L; Marcipar I; Bottasso OA
Can J Cardiol; 2014 Mar; 30(3):332-7. PubMed ID: 24370375
[TBL] [Abstract][Full Text] [Related]
32. PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients.
Damasio MPS; Rocha MOC; Sousa GR; Ferreira KS; Fares-Gusmão RCG; Medeiros NI; Araujo FF; Chaves AT; Dutra WO; Correa-Oliveira R; Gomes JAS
Hum Immunol; 2019 Jul; 80(7):517-522. PubMed ID: 30853363
[TBL] [Abstract][Full Text] [Related]
33. The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function.
Sousa GR; Gomes JA; Damasio MP; Nunes MC; Costa HS; Medeiros NI; Fares RC; Chaves AT; Corrêa-Oliveira R; Rocha MO
PLoS One; 2017; 12(3):e0172833. PubMed ID: 28278264
[TBL] [Abstract][Full Text] [Related]
34. Chagas' disease: IgG isotypes against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage.
Cerban FM; Gea S; Menso E; Vottero-Cima E
Clin Immunol Immunopathol; 1993 Apr; 67(1):25-30. PubMed ID: 8443982
[TBL] [Abstract][Full Text] [Related]
35. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications.
Goin JC; Leiros CP; Borda E; Sterin-Borda L
FASEB J; 1997 Jan; 11(1):77-83. PubMed ID: 9034169
[TBL] [Abstract][Full Text] [Related]
36. Analysis of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas' disease.
Morgan J; Colley DG; Pinto Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Powell MR
J Parasitol; 1998 Jun; 84(3):641-3. PubMed ID: 9645878
[TBL] [Abstract][Full Text] [Related]
37. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.
Solana ME; Katzin AM; Umezawa ES; Miatello CS
J Clin Microbiol; 1995 Jun; 33(6):1456-60. PubMed ID: 7650167
[TBL] [Abstract][Full Text] [Related]
38. Detection of T. cruzi antigens reactive with IgG antibodies from patients with chronic Chagas' disease.
Gea S; Evequoz C; Rodríguez P; Vottero-Cima E
Medicina (B Aires); 1986; 46(2):163-6. PubMed ID: 3553838
[No Abstract] [Full Text] [Related]
39. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
[TBL] [Abstract][Full Text] [Related]
40. IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi.
de Melo AS; de Lorena VM; de Moura Braz SC; Docena C; de Miranda Gomes Y
Cytokine; 2012 May; 58(2):207-12. PubMed ID: 22325340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
